Pharmacogenomics

Individualizing infertility therapy with pharmacogenomics: vanity or vanguard?
pp. 1179-1181(3)
Author: Legro, Richard S

Researchers identify genetic variant implicated in lupus risk
pp. 1183-1185(3)

Interview
pp. 1187-1190(4)
Author: Rozen, Rima

Research Highlights
pp. 1191-1194(4)
Authors: Cattaneo, Dario; Ranganathan, Prabha; Kieling, Christian; Rohde, Luis Augusto

Pharmacogenetic relevance of MTHFR polymorphisms
pp. 1195-1206(12)
Authors: Toffoli, Giuseppe; De Mattia, Elena

Pharmacogenomic importance of pravastatin
pp. 1207-1210(4)
Authors: Peters, Bas; Maitland-van der Zee, Anke-Hilse

Sequenom , Inc.
pp. 1211-1215(5)
Authors: Cullinan, Amy; Cantor, Charles

Association between a frequent allele of the gene encoding OATP1B1 and enhanced LDL-lowering response to fluvastatin therapy
pp. 1217-1227(11)
Authors: Couvert, Philippe; Giral, Philippe; Dejager, Sylvie; Gu, Jessie; Huby, Thierry; Chapman, M John; Bruckert, Eric; Carrié, Alain

Variations in the UDP-glucuronosyltransferase 1A1 gene for the development of unconjugated hyperbilirubinemia in Taiwanese
pp. 1229-1235(7)
Authors: Huang, Yang-Yang; Huang, May-Jen; Yang, Sieng-Sien; Teng, Hsiu-Chen; Huang, Ching-Shan

Effects of CYP2C9 and VKORC1 on INR variations and dose requirements during initial phase of anticoagulant therapy
pp. 1237-1250(14)
Authors: Spreafico, Marta; Lodigiani, Corrado; van Leeuwen, Y; Pizzotti, Denise; Rota, Lidia L; Rosendaal, FR; Mannucci, Pier M; Peyvandi, Flora

CYP2C19 and nongenetic factors predict poor responsiveness to clopidogrel loading dose after coronary stent implantation
pp. 1251-1259(9)
Authors: Geisler, Tobias; Schaeffeler, Elke; Dippon, Juergen; Winter, Stefan; Buse, Verena; Bischofs, Christian; Zuern, Christine; Moerike, Klaus; Gawaz, Meinrad; Schwab, Matthias

Use of plasmid-derived external quality control samples in pharmacogenetic testing
pp. 1261-1266(6)
Authors: van der Straaten, Tahar; Swen, Jesse; Baak-Pablo, Renee; Guchelaar, Henk-Jan

Pharmacogenetic insights into codeine analgesia: implications to pediatric codeine use
pp. 1267-1284(18)
Authors: Madadi, Parvaz; Koren, Gideon

Genetic underpinnings of tardive dyskinesia: passing the baton to pharmacogenetics
pp. 1285-1306(22)
Authors: Thelma, BK; Srivastava, Vibhuti; Tiwari, Arun Kumar

Genetic variation in the dopamine pathway and smoking cessation
pp. 1307-1321(15)
Authors: David, Sean P; Munafò, Marcus R

Identifying genetic components of drug response in mice
pp. 1323-1330(8)
Author: Cotsapas, Chris

Ethnic differences in warfarin maintenance dose requirement and its relationship with genetics
pp. 1331-1346(16)
Authors: Schelleman, Hedi; Limdi, Nita A; Kimmel, Stephen E

Genetic factors that confer sensitivity to HAART in HIV-infected subjects: implication of a benefit of an earlier initiation of HAART
pp. 1347-1351(5)
Authors: Nakajima, Toshiaki; Kimura, Akinori

Brain-derived neurotrophic factor and antidepressant action: another piece of evidence from pharmacogenetics
pp. 1353-1358(6)
Authors: Tsai, Shih-Jen; Hong, Chen-Jee; Liou, Ying-Jay

Acknowledgements
pp. 1371-1371(1)